This is NOT the currently viral Turing Pharmaceuticals's hike of Daraprim's price (http://www.nytimes.com/2015/09/21/business/a-huge-overnight-...) that's being rescinded. I had no idea that this practice of buying up patents and increasing drug prices is so common. Sounds like the pharmaceuticals market is full of some very unethical folks.